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SIGNIFICANCE STATEMENT 16 
 17 
The availability of protocols supporting genetic complementation of Eimeria tenella has raised the 18 
prospect of generating transgenic parasite lines which can function as vaccine vectors expressing and 19 
delivering heterologous proteins from other Eimeria species, but also from other pathogens of 20 
veterinary or zoonotic significance which can infect poultry. Current protocols can also be used to 21 
expand biological understanding about the Eimeria species through reverse genetics. 22 
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ABSTRACT 28 
 29 
Eimeria is a genus of apicomplexan parasites that contains a large number of species, most of which are 30 
absolutely host-specific. Seven species have been recognised to infect chickens. Infection of susceptible 31 
chickens results in an intestinal disease called coccidiosis, characterised by mucoid or haemorrhagic 32 
enteritis, and associated with an impaired feed conversion or mortality in severe cases. Intensive farming 33 
practices have increased the significance of coccidiosis since parasite transmission is favoured by high-34 
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density housing of large numbers of susceptible chickens. Routine chemoprophylaxis and/or 35 
vaccination with live parasite vaccines provides effective control for Eimeria, although the emergence 36 
of drug resistance and the relative cost and production capacity of current vaccine lines can prove 37 
limiting. As pressure to reduce drug use in livestock production intensifies novel vaccination strategies 38 
are needed. Development of effective protocols supporting genetic complementation of Eimeria species 39 
has until recently been hampered by their inability to replicate efficiently in vitro. Now, the availability 40 
of such protocols has raised the prospect of generating transgenic parasite lines that function as vaccine 41 
vectors to express and deliver heterologous antigens. For example, this technology has the potential to 42 
streamline the production of live anticoccidial vaccines through the generation of parasite lines that co-43 
express immunoprotective antigens derived from multiple Eimeria species. In this paper we describe 44 
detailed protocols for genetic manipulation, laboratory growth and in vivo propagation of Eimeria 45 
tenella parasites which will encourage future work from other researchers to expand biological 46 
understanding of Eimeria through reverse genetics. 47 
 48 
INTRODUCTION 49 
 50 
Coccidiosis is a common disease caused by apicomplexan parasites of the genus Eimeria. To date, more 51 
than 1,200 Eimeria species have been described infecting birds, mammals, reptiles or amphibians, most 52 
with absolute host-specificity. Coccidiosis is a major cause of poor performance and mortality in 53 
domestic livestock, with greatest economic significance in production of poultry. Seven Eimeria species 54 
can infect chickens and co-infection is common. Modern husbandry systems including large numbers 55 
of chickens reared at high stocking densities provide an ideal environment for successful parasite 56 
transmission (Chapman, 2014; Shirley, Smith, & Tomley, 2005). Current control options include dietary 57 
supplementation with anticoccidial drugs and/or vaccination with live parasites, combined with careful 58 
husbandry (Blake & Tomley, 2014). However, commercial availability of the existing live attenuated 59 
vaccines is constrained by the capacity of their production, which still relies on the use of live chickens 60 
(Williams, 1998). Further, the routine use of anticoccidial chemoprophylaxis is increasingly coming under 61 
public and legislative spotlights due to the potential, albeit not proven, presence of drug residues in the 62 
food chain and environment, and widespread resistance caused by intensive drug use (Chapman, 1997; 63 
Jenkins, Parker, & Ritter, 2017). 64 
The availability of techniques to transfect exogenous DNA has expanded knowledge on the biology of 65 
many apicomplexan parasites such as Toxoplasma gondii and some Plasmodium species, allowing the 66 
dissection of specific gene functions. This has been made possible thanks to the availability of effective 67 
in vitro systems to obtain and select specific parasite populations, but also knowledge of relevant 68 
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regulatory DNA sequences (Sibley, Messina, & Niesman, 1994; Soldati & Boothroyd, 1993). In contrast, 69 
for many years the inability of Eimeria species to efficiently complete their lifecycle in vitro and a lack of 70 
knowledge about regulatory DNA sequences obstructed development of effective protocols for stable 71 
transfection (Kelleher & Tomley, 1998). Eimeria species feature an oral-faecal homoxenous lifecycle that 72 
involves three phases of replication: schizogony (or merogony), gametogony and sporogony (or 73 
sporulation). Sporulated oocysts are the infective transmission stage, containing four sporocysts with 74 
two sporozoites in each. When ingested, the sporozoites are released and penetrate epithelial cells of 75 
the intestine, where they replicate asexually through several rounds of schizogony, each producing 76 
numerous merozoites. This is followed by gametogony, in which merozoites develop into macro and 77 
microgamonts and produce macro and microgametes (sexual replication). Fertilisation of 78 
macrogametes by biflagellated microgametes results in the production of oocysts (zygotes) that are 79 
excreted in the faeces. Once in the environment, unsporulated oocysts undergo sporogony and form 80 
sporocysts containing infective sporozoites.  81 
Current advances in genetic manipulation of sporozoites from different Eimeria species have now 82 
allowed the generation of stable populations expressing specific selectable markers (see Figure 1 for 83 
outline) (Clark et al., 2008; Yan et al., 2009). Access to high-throughput next-generation genomic and 84 
transcriptomic sequencing data for Eimeria parasites can now be exploited towards the identification of 85 
specific promoters capable of inducing low to high transcription levels of transfected gene(s) in a 86 
constitutive or stage-specific manner (Marugan-Hernandez, Long, Blake, Crouch, & Tomley, 2017; Reid 87 
et al., 2014). The development of these protocols has prompted the idea to utilise Eimeria parasites (e.g. 88 
Eimeria tenella) to express immunoprotective antigens from other Eimeria species (e.g. antigen A from 89 
Eimeria maxima and antigen B from Eimeria necatrix) as live vaccines, thus inducing immunity against 90 
the vector (E. tenella) and the antigen donors (E. maxima and E. necatrix). This approach could streamline 91 
commercial vaccine formulations from up to eight Eimeria species/strains, due to the lack of cross-92 
protective immunity, to just a few lines expressing relevant antigens from all other species (Blake & 93 
Tomley, 2014). The toolbox would also allow expression of additional antigens directed against other 94 
pathogens which affect poultry, even modifying their trafficking within the parasite to target antigen 95 
exposure to the host immune system (Clark et al., 2012; Marugan-Hernandez et al., 2016; Marugan-96 
Hernandez et al., 2017; Pastor-Fernandez et al., 2018; Tang et al., 2017). 97 
Herein we discuss the current limitations of in vitro and in vivo propagation, as well as transfection when 98 
applied to Eimeria spp. and the key factors determining transfection success including plasmid 99 
development and methods to improve rates of DNA integration. We provide detailed protocols for 100 
genetic manipulation, laboratory growth and in vivo propagation of Eimeria tenella parasites which can 101 
potentially be used to expand knowledge about Eimeria spp. through reverse genetics. 102 
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STRATEGIC PLANNING  103 
 104 
Parasite species/strain selection 105 
 106 
Of the seven Eimeria species that infect chickens, E. tenella is most effective at invading, replicating and 107 
developing in vitro in a range of primary cells and stablished cell lines (most notably the E. tenella 108 
Wisconsin strain) (Doran, 1974). Nevertheless, efficient in vitro development is still limited to the early 109 
asexual stages, failing to support efficient production of oocysts (Bussière et al., 2018). In addition, E. 110 
tenella preferentially replicates in the caeca, which simplifies its harvest from caecal scrapes instead of 111 
faecal samples (Eckert J., 1995). This approach also reduces the amount of clinical waste generated 112 
during parasite maintenance and simplifies adherence to relevant regulations regarding genetically 113 
modified organisms.  114 
 115 
Chickens and Facilities 116 
 117 
High quality Eimeria oocysts can only be obtained by in vivo passage using coccidia-free chickens. 118 
However, different chicken breeds/strains display different susceptibility to infection by each Eimeria 119 
species. We recommend to perform initial studies to determine the oocyst/sporozoite dose that 120 
provides maximum oocyst yield with minimum pathology for each species of interest (Bumstead & 121 
Millard, 1992; Smith, Hesketh, Archer, & Shirley, 2002). The use of chickens from a specific pathogen 122 
free (SPF) flock is not necessary as long as chicks are reared under coccidia-free conditions from hatch 123 
onwards. Food rations should be bought from suppliers of high quality diets for laboratory animals, and 124 
always free of anticoccidial drugs unless required for selection of resistance (the use of medicated feed 125 
is common within the poultry industry). National and international animal welfare regulations on 126 
housing, husbandry and care of animals should be considered. 127 
 128 
Safety Concerns 129 
 130 
Eimeria parasites are enzootic wherever chickens are farmed, ranked in the lowest risk group by the 131 
Department for the environment, fisheries and rural affairs (Defra, UK), and not zoonotic. However,  while 132 
biological containment is not required it is beneficial to work under containment level 2 conditions, 133 
including lab coats and disposable gloves, to maintain biological purity of parasite lines. Access to 134 
isolated ventilation systems that allow fumigation with ammonia is beneficial.  135 
Generation of transgenic parasite lines expressing foreign proteins and/or resistance to medically 136 
important drugs should be carefully managed, since these parasites should not be released to the 137 
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environment. Once transfected, parasites must be considered as genetically modified organisms (GMO), 138 
and therefore, relevant local and national regulations must be reviewed and followed including waste 139 
disposal. 140 
 141 
Handling of Infectious Oocysts 142 
Sporulated oocysts can be stored in PBS (see Reagents & Solutions), water, or 2% potassium dichromate 143 
at ~4 ºC, ideally in glass, and used for up to six months.  144 
 145 
Development of constructs for transfection 146 
 147 
Success of Eimeria transfection relies on the design of appropriate constructs, the use of specific 148 
electroporation protocols, and the purification of fresh and viable parasites. Transfection constructs are 149 
modifications of commercially available plasmids that are subsequently complemented with a variety of 150 
elements which may encode regulatory sequences, the coding sequence(s) of interest, fluorescent 151 
reporters, drug markers, etc. To date all published transfection plasmids support ampicillin selection, 152 
indicating they can be easily propagated using competent Escherichia coli cells, and purified using a 153 
broad range of commercial kits (from miniprep to gigaprep, depending on the size of the bacterial 154 
culture and corresponding plasmid yield). 155 
 156 
a) Selection of regulatory regions to promote heterologous expression 157 
A number of 5' and 3' endogenous regulatory regions have been successfully identified from Eimeria 158 
genomes and used to drive expression of different exogenous genes (normally fluorescent reporters), 159 
most commonly in E. tenella. These include promoters from constitutively expressed genes, such as 160 
actin, beta tubulin and histone H4, but also other regulatory regions from genes expressed during 161 
specific stages of the parasite lifecycle such as those encoding microneme proteins (MIC) 1, 2, 3 and 5, 162 
and the surface antigen (SAG) 13 from the zoite stages, as well as the Gam56 protein from the sexual 163 
stages (Clark et al., 2008; Hanig, Entzeroth, & Kurth, 2012; Hao, Liu, Zhou, Li, & Suo, 2007; Kelleher & 164 
Tomley, 1998; Kurth & Entzeroth, 2009; Marugan-Hernandez et al., 2016; Marugan-Hernandez et al., 165 
2017; Tang et al., 2017). Thus, the choice of promoter can determine whether the transgene is expressed 166 
throughout the entire parasite lifecycle, or is restricted to specific lifecycle stages. Interestingly, 167 
promoters from T. gondii involved in the expression of the Tgtubulin and Tgsag1 genes have also been 168 
used effectively to induce the expression of fluorescent reporters in transfected E. tenella parasites (Zou 169 
et al., 2009), and the same has been described for the Etactin, Etmic1 and Etgam56 promoters in 170 
transfected E. nieschulzi parasites (Hanig et al., 2012; Kurth & Entzeroth, 2009). Recent transcriptome 171 
analysis of E. tenella has made available the relative transcript abundance from different stages of its 172 
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lifecycle, demonstrating that some of these genes are transcribed at lower or higher levels relative to 173 
others (Reid et al., 2014; Walker et al., 2015). These data can be now exploited to test new putative 174 
promoter regions and induce higher levels of expression of the gene of interest in transgenic 175 
populations.  176 
For this purpose, we selected nine genes with constitutive or varied stage-specific expression that are 177 
transcribed at high or medium levels to produce a flexible tool kit, cloned their putative 5' regulatory 178 
regions, and tested their ability to induce higher levels of expression of the mCitrine reporter in E. tenella 179 
transfected sporozoites (Table 1). Transfection with the promoter region Et8, which regulates expression 180 
of the Translation Initiation Factor (TIF), induced the highest fluorescence levels in transgenic parasites, 181 
which were comparable to those obtained in sporozoites transfected with mCitrine under the control of 182 
the Etmic1 promoter. For this reason, we selected this promoter to drive expression of foreign genes in 183 
E. tenella (Marugan-Hernandez et al., 2016). Similarly, transfection with the promoter region Et9 induced 184 
high levels of fluorescence in transgenic sporozoites, and this was comparable to the levels achieved by 185 
transfecting sporozoites with mCitrine under the control of the Etactin promoter (Table 1). 186 
 187 
b) Use of markers for selection of transgenic Eimeria  188 
Transfected parasites can easily be identified and selected by the inclusion of reporter genes within 189 
transfection constructs. The first report describing the transient transfection of E. tenella employed the 190 
beta-galactosidase gene as a reporter (Kelleher & Tomley, 1998), but due to ease of use all subsequent 191 
studies have opted to use fluorescent proteins. The expression of these reporters permits not only 192 
assessment of the efficiency of transfection by simple microscopic visualization, but also allows the 193 
selective isolation of transgenic (fluorescent) oocysts by flow-activated cell sorting (FACS) from progeny 194 
individuals (those obtained after infecting chickens with transfected sporozoites) and verification of the 195 
expression and localisation of a protein of interest when it is fused to a reporter protein (Clark et al., 196 
2008; Marugan-Hernandez et al., 2016; Marugan-Hernandez et al., 2017; Pastor-Fernandez et al., 2018; 197 
Yan et al., 2009). Notably, transfection efficiency does not seem to be affected by the choice of different 198 
fluorescent reporters (mCherry, tdTomato, mCitrine, YFPmYFP or AmCyan) in E. tenella (Clark et al., 199 
2008).  200 
In addition to reporter proteins, the use of drug-resistance genes also provides an advantage for 201 
positive selection of transgenic Eimeria. For example, pyrimethamine is a drug approved to treat 202 
toxoplasmosis and some forms of malaria, but it is also effective against Eimeria. This compound inhibits 203 
dihydrofolate reductase–thymidylate synthase (DHFR-TS), a key enzyme required for the synthesis of 204 
DNA and proteins in protozoa. Earlier experiments carried out in T. gondii resulted in the generation of 205 
the DHFR-TSm2m3 gene, a mutated form which codes for a version of the enzyme that is not inhibited 206 
by pyrimethamine treatment (Donald & Roos, 1993). Transfection of the DHFR-TSm2m3 gene coupled 207 
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with subsequent dietary pyrimethamine supplementation has been proven to be an efficient way to 208 
obtain stable transgenic populations of Eimeria parasites (Clark et al., 2008; Pastor-Fernandez et al., 209 
2018; Qin et al., 2016; Tang et al., 2017; Yan et al., 2009). Furthermore, dual selection approaches by 210 
transfection with genes coding for a fluorescent reporter and pyrimethamine resistance (either in a 211 
single or in two different plasmids) has been found to speed up the generation of stable populations 212 
(Clark et al., 2008; Hanig et al., 2012). However, the generation of strains resistant to medically important 213 
drugs should be carefully managed and limited to experimental uses, since these parasites should not 214 
be released to the environment (see Safety Concerns).   215 
 216 
Methods for the optimisation of DNA integration 217 
 218 
a) Restriction enzyme mediated integration  219 
Transfection efficiency in Eimeria spp. has been greatly improved by the use of restriction enzyme 220 
mediated integration (REMI) techniques (Clark et al., 2008; Kurth & Entzeroth, 2009; Liu et al., 2008). This 221 
method relies on linearisation of the transfection plasmid with a restriction enzyme combined with the 222 
addition of the same enzyme to the transfection mix before shock, apparently improving plasmid 223 
integration into the genome at open sites that have been generated by the endonuclease (Schiestl & 224 
Petes, 1991). This results in a largely random and heterologous integration of the plasmid into the 225 
parasite genome. Using E. tenella as a model, Liu and colleagues demonstrated that transfection 226 
efficiency was considerably higher in sporozoites transfected with linearised plasmids (increased by 227 
6,900 %) and PCR amplicons (increased by 2,490 %), compared to non-linearised plasmids. In addition, 228 
they showed that co-transfection with the restriction enzyme used for plasmid digestion also increased 229 
transfection efficiency by 215 % for linearised plasmids and 37 % for PCR amplicons (Liu et al., 2008). 230 
Therefore, we always opt for the combination of linearised plasmids with their respective restriction 231 
enzymes to obtain high frequency integration. Nevertheless, it has been shown that REMI performance 232 
also depends on the starting amount of DNA used and the choice of restriction enzyme employed for 233 
transfection, as discussed below. 234 
 235 
a.1) Effect of plasmid concentration and size on transfection efficiency 236 
To date, transfection of E. tenella sporozoites has been performed using a broad range of plasmid 237 
concentrations (Clark et al., 2008; Liu et al., 2013; Yan et al., 2009). However, these studies have not 238 
directly evaluated the effect of DNA starting concentration on transfection efficiency, which has now 239 
been found to have a dose dependent effect. Experiments completed in our group with E. tenella 240 
sporozoites transfected with 1.5 to 12 µg of the pEtenREPORTER plasmid that confers green 241 
fluorescence to the transfected parasites (p5’UTR-EtMIC1_mCitrine_3’UTR-Actin, from (Clark et al., 242 
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2008)) have shown that the greater the concentration of DNA, the higher the percentage of fluorescent 243 
oocysts generated after transfection and in vivo passage (Figure 2). 244 
We previously described a negative correlation between plasmid size and efficiency of transfection: 245 
increasing the size of a given plasmid by 33–50% resulted in a decreased efficiency of transient 246 
transfection between 10- and 25-fold. Since FACS enrichment of progeny oocysts has been shown to 247 
be efficacious for selection of transfected lines, constructs containing a single fluorescent reporter is 248 
adequate for many studies and reduces the impact of construct size (Clark et al., 2008). 249 
 250 
a.2) Effect of restriction enzyme choice on transfection efficiency 251 
The first examples of REMI using Saccharomyces cerevisiae and Dictyostelium spp. hypothesized that the 252 
mechanism of transgene integration was based on a simple ligation-repair model (Kuspa & Loomis, 253 
1992; Schiestl & Petes, 1991). However, a later study reported that transfection efficiency of T. gondii 254 
was dependent on the restriction enzyme used, and that the same enzyme does not need to be used 255 
for linearisation and electroporation (Black, Seeber, Soldati, Kim, & Boothroyd, 1995). In order to assess 256 
this in Eimeria spp., we analysed in silico the pEtenREPORTER plasmid (Clark et al., 2008) to find single 257 
restriction sites not present within promoter or coding regions, and selected PsiI and ScaI enzymes for 258 
REMI. In silico digestions of the E. tenella genome showed a difference of 6.7% in the number of sites 259 
per genome for both enzymes (Psil = 7547; Scal = 7075). Of these sites, there was a 20% reduction of 260 
Psil in predicted coding regions compared to ScaI (Psil = 1775, Scal = 2220), which suggests a greater 261 
risk of coding sequence disruption for Scal compared to Psil. Subsequently, PsiI and ScaI enzymes were 262 
used to linearize the pEtenREPORTER plasmid and added to the transfection reaction prior to 263 
electroporation (0.5 U/condition). A total of 5 µg and 3.5 µg of PsiI and ScaI-digested plasmids were 264 
used to transfect freshly purified sporozoites. For all plasmid starting concentrations, Psil-transfected 265 
populations resulted in a higher proportion of transgenic parasites, a higher average fluorescence 266 
intensity and greater parasite survival, supporting our in silico findings (Figure 3). These results highlight 267 
the importance of careful selection and testing of restriction enzymes for transfection. 268 
 269 
b) Transfection technologies 270 
Effective transfection of Eimeria parasites has been achieved by electroporation (BTX or BioRad’s 271 
GenePulser™ systems) or nucleofection (AMAXA™ system, Lonza), utilising a wide range of conditions 272 
and buffers. However, the switch from electroporation to nucleofection technology, which allows DNA 273 
to enter directly into the nucleus, has improved the poor transfection rates reported earlier (Clark et al., 274 
2008; Hao et al., 2007; Kelleher & Tomley, 1998; Marugan-Hernandez et al., 2016). When compared to 275 
BTX electroporation, use of the AMAXA™ Nucleofector II system improved efficiency of transient E. 276 
tenella transfections up to 3.6-fold using a cytomix buffer and preset program U-33. This efficiency was 277 
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directly comparable with that noted for the closely related T. gondii (Clark et al., 2008). Due to the 278 
availability of new and improved nucleofection systems, optimal conditions for E. tenella transfection 279 
using the AMAXA™ 4D-Nucleofector™ System, the 16-well Nucleocuvette™ Strips, and a range of 280 
transfection buffers have been standardised here (Table 2). The combination of P3 buffer and program 281 
EO-114 successfully generated transfected sporozoites. Besides, the use of a 16-well strip system 282 
provided ideal conditions for screening multiple constructs and transfection conditions at the same 283 
time, using relatively small numbers of parasites. 284 
 285 
c) Stability of the transgenes 286 
The experiments carried out in our group using transgenic populations obtained by REMI transfection 287 
and nucleofection, and successively propagated in chickens using FACS selection, have shown a dramatic 288 
decrease in transgene insertion numbers after two passages (Figure 4A). We observed similar results in 289 
parasites propagated in chickens using FACS and pyrimethamine selection, which were phenotypically 290 
stable after three passages (100% fluorescent oocysts after caecal harvest) and displayed an average 291 
insertion of 10-15 transgene copies per E. tenella genome (Clark et al., 2008). Interestingly, in vivo 292 
propagation seemingly helped to stabilise these populations, since average transgene copy numbers 293 
tend to decrease, whereas percentage of transgenic parasites tends to increase by successive passage 294 
(Figure 4B). This suggests that there is a selection pressure against parasites expressing higher numbers 295 
of transgenes, and therefore, more passages would be needed to obtain stable integration of exogenous 296 
DNA.  297 
 298 
BASIC PROTOCOL 1: Cracking, hatching and purification of Eimeria tenella parasites 299 
 300 
The protective walls of the oocyst and sporocyst makes direct transfection impossible using current 301 
technologies. To date, sporozoites present in these structures need to be released through physical, 302 
chemical and enzymatic disruption (cracking and hatching), and subsequently purified using columns 303 
based on anion exchange chromatography. Purified sporozoites are only viable for a short period of 304 
time, as they are required to invade host cells to carry on with their cycle. Thus, the cracking and hatching 305 
must be followed by transfection and subsequent in vitro (cell culture) or in vivo (chicken) infection. In 306 
this protocol we describe the necessary steps to release sporozoites from E. tenella oocysts, and clean 307 
them up from oocyst and sporocyst debris in readiness for transfection.  308 
 309 
 310 
 311 
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Materials 312 
- Sporulated oocysts of E. tenella in H2O or PBS (produced in-house, see BASIC PROTOCOL 3: In vivo 313 
propagation of transgenic E. tenella). 314 
- Sterile saturated salt solution (SSS, see Reagents & Solutions). 315 
- Sterile phosphate buffered saline (PBS, see Reagents & Solutions). 316 
- Sterile diethylaminoethyl cellulose (see Reagents & Solutions). 317 
- Hatching solution (see Reagents & Solutions). 318 
- 1M MgCl2 solution in ultrapure water. 319 
- Eluting buffer (PBS-1% glucose, see Reagents & Solutions). 320 
- Ballotini SiLibeads® solid soda glass beads, 0.4-0.6 mm diameter (Catalogue No: 201-0465, VWR). 321 
- 20 mL-disposable syringes (slip tip). 322 
- Sterile Erlenmeyer flask (borosilicate glass, narrow neck, 250 ml, catalogue No: 1130/14D, Pyrex). 323 
- Nylon wool fiber (Catalogue No: 18369, Polysciences Inc). 324 
- Set of two pet slicker brushes with fine wire. 325 
- Micropipettes, tips, pipette controller and serological pipettes.  326 
- Swing bucket centrifuge. 327 
- Vortex mixer. 328 
- Optical microscope. 329 
- Water bath. 330 
- Small measuring cylinders or retort stands. 331 
- Parafilm.  332 
- Cell counting chambers (modified Fuchs Rosenthal, catalogue No: AC6000, Hawksley). 333 
 334 
Procedure 335 
1. Using a cell counting chamber (modified Fuchs Rosenthal), estimate the concentration of the oocyst 336 
stock by loading 10 μl of the culture per chamber and counting them at 10X/10X magnification 337 
under the optical microscope. If oocysts concentration is too high to count, dilute the stocks in H2O 338 
or PBS (1:10 to 1:100) until parasite numbers are adequate for an accurate count, correcting the 339 
final concentration accordingly.  340 
2. Pellet 10-50x106 oocysts using a swing bucket centrifuge (750 x g for 10 min) in a 50 ml universal 341 
tube, and re-suspend in 3 ml of PBS. If more parasites are required, prepare them in a different 50 342 
ml universal tube. 343 
3. Add the glass beads (1:1 proportion, oocysts suspension:beads) and crack parasites by vortexing 344 
for 15 sec bursts until most of the oocysts have released their sporocysts. Check oocysts 345 
microscopically between bursts to ensure sporocyst release. Repeat this process as many times as 346 
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necessary, aiming to get a good balance between breakage of oocyst walls and maintenance of 347 
sporocyst integrity.  348 
If damaged sporocysts or released sporozoites can be seen, cracking should stop as excessive cracking 349 
will reduce the final yield of purified sporozoites (see Figure 5A). 350 
When very fresh oocysts are employed, wall cracking may be difficult. In these cases, resuspension of 351 
oocysts in 1.2% sodium hypochlorite solution (prepared from 12% sodium hypochlorite solution, 352 
Catalogue No: 301696S, VWR Chemicals) for 10 minutes, followed by three PBS washes by 353 
centrifugation (750 x g for 10 min), may help to soften the oocyst walls and improve cracking 354 
efficiency.  355 
4. Transfer the resulting sporocyst/oocyst/debris suspension to a 250 ml Erlenmeyer flask by washing 356 
the beads by pipetting with 40 ml of hatching solution. 357 
5. Incubate the sporocyst/oocyst/debris suspension for 30 min at 41 ºC in a water bath, and check the 358 
hatching progress microscopically.  359 
6. Supplement hatching solution with 1 M MgCl2 to a final concentration of 10 mM (500 μl 1 M MgCl2 360 
per 50 ml of hatching solution added). 361 
7. Incubate the sporocyst/oocyst/debris suspension for an additional 1 h at 41 ºC. Mix gently every 30 362 
min and check hatching progress microscopically. 363 
8. Prepare a suitable number of purification columns during the parasite excystation (Figure 5). One 364 
20 ml syringe column is sufficient for up to ~50x106 oocysts. 365 
a. Use two pet slicker brushers to tease out small bunches of nylon wool and remove any knots 366 
by brushing.  367 
b. Fill the syringe barrel with the teased-out wool to a depth of 5 ml. Gently push the wool to the 368 
bottom using the plunger. 369 
The use of non-teased out nylon wool and/or its excessive compression within the column may 370 
result in lower recovery yields.  371 
c. Place the column on a measuring cylinder or in a retort stand and wash through nylon wool 372 
with 10 ml of eluting buffer. 373 
d. Before all the eluting buffer has run out, pour sterile DE-52 on top of the nylon wool up to a 10 374 
ml depth and allow the excess fluid to drain out. Ensure that the column does not dry. 375 
e. Wash column through with 20 ml of eluting buffer and plug syringe nozzle with parafilm. Make 376 
sure that there is still a little excess of buffer in the column to prevent drying out. 377 
9. Once hatching has finished, enumerate the total number of sporozoites using a cell counting 378 
chamber. 379 
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10. Pellet sporozoites in a 50 ml universal tube using a swing bucket centrifuge (500 x g for 10 min), 380 
remove hatching solution carefully using a serological pipette, and re-suspend pellet in 30 ml of 381 
elution buffer. Check microscopically that the supernatant does not contain non-pelleted 382 
sporozoites, try to recover them by centrifugation, and re-suspend pellet in elution buffer if 383 
necessary.  384 
11. Gently pour the sporozoite suspension into the top of a separation column, transfer column to a 385 
new 50 ml universal tube, and unplug.  386 
12. Collect at least 50 ml in different fractions from each column by topping up regularly with eluting 387 
buffer. Since the wall debris tends to pellet and block the column, regularly use a 1 ml serological 388 
pipette to gently stir the interphase between the DE-52 and the sporozoites suspension.  389 
13. Monitor eluate microscopically by taking droplets on microscope slides from every fraction 390 
recovered. Once sporozoite numbers are reduced, residual parasites can be 'pushed' through the 391 
column by replacing the plunger and exerting pressure gently.  392 
Pushing too hard can result in debris and sporocysts coming through.  393 
If contamination with DE-52, sporocysts, or any other debris is considered to be excessive the relevant 394 
fraction can be passed through a fresh column or discarded. 395 
14. Pellet sporozoites in a 50 ml universal tube using a swing bucket centrifuge (500 x g for 10 min), 396 
resuspend in fresh PBS and enumerate parasite numbers using a cell counting chamber. Compare 397 
starting and final numbers of sporozoites to estimate percentage of recovery and identify issues 398 
related to the column purification.  399 
15. Once excysted, sporozoites should be handled with care, and their infectivity will drop after 1-2 400 
hours. 401 
 402 
BASIC PROTOCOL 2: Transfection of E. tenella sporozoites 403 
 404 
This protocol describes the methods for successful transfection of freshly purified E. tenella sporozoites 405 
using REMI and nucleofection approaches. Other relevant factors such as plasmid preparation are also 406 
discussed. The protocol is optimized for transfection of 1x106 sporozoites with 12 µg of linearized 407 
plasmid and 6 units of the chosen restriction enzyme. The Nucleocuvette™ Strips allow up to 16 408 
independent transfections in a single assay, so different constructs, restriction enzymes, numbers of 409 
parasites, and DNA starting concentrations can be assessed to optimize specific needs in a single 410 
experiment. 411 
 412 
 413 
 414 
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Materials 415 
- Freshly hatched E. tenella sporozoites (see BASIC PROTOCOL 1: Cracking, hatching and purification 416 
of Eimeria tenella parasites). 417 
- Linearized transfection constructs (see Development of constructs for transfection and Effect of 418 
plasmid concentration and size on transfection efficiency).  419 
- Selected restriction enzyme for REMI (see Effect of restriction enzymes on transfection efficiency). 420 
- Micro-volume Spectrophotometer. 421 
- Amaxa™ 4D-Nucleofector™ (core and X units for nucleofection in suspensions, catalogue No: AAF-422 
1002B and AAF-1002X, Lonza). 423 
- Amaxa™ P3 Primary Cell 4D-Nucleofector™ X Kit (includes transfection buffer and 16-well 424 
Nucleocuvette™ Strips, Catalogue No: V4XP-3032, Lonza) (see Transfection technologies). 425 
- CO2 incubator. 426 
- Roswell Park Memorial Institute (RPMI)-1640 medium with L-glutamine, sodium bicarbonate and 427 
phenol red (Catalogue No: R8758, Sigma-Aldrich). 428 
- 0.4% Trypan Blue solution (Catalogue No: T8154, Sigma-Aldrich). 429 
- Flat bottom 96-well cell culture plate (Catalogue No: 266120, Nunc). 430 
- Micropipettes, tips, pipette controller and serological pipettes.  431 
- Cell counting chambers (modified Fuchs Rosenthal). 432 
 433 
Procedure 434 
1. Linearized plasmids for REMI should be ready in advance to avoid unnecessary delay in transfection 435 
and consequent loss of sporozoite viability:  436 
a. Plasmids are commonly propagated using E. coli competent cells (e.g. XL1-Blue strain, from 437 
Agilent), purified using column-based kits (e.g. Plasmid Midi Kit from QIAGEN, for up to 100 µg 438 
of plasmid DNA), quantified using a spectrophotometer, and digested overnight using 439 
restriction enzymes that cut them in a single site upstream of the expression cassette (e.g. PsiI, 440 
digesting in the region upstream the EtMic1 promoter fused to the mCitrine reporter gene as 441 
in Clark et al., 2008). 442 
b. In order to concentrate the plasmid and avoid interference of digestion buffer with transfection 443 
buffer, digested plasmids need to be cleaned up by precipitation following these steps: 444 
i. Add to the digestion mix 1/10 volumes of 3M sodium acetate and 3 volumes of 445 
absolute ethanol. 446 
ii. Incubate sample at -20 ºC for 30 min to 16 hours. Then, centrifuge at 14,000 x g for 30 447 
min at 4 ºC. 448 
iii. Discard supernatant and wash pellet with 70% (v/v) ethanol. 449 
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iv. Centrifuge at 14,000 x g for 30 min at 4 ºC. 450 
v. Discard supernatant and re-suspend pellet with transfection buffer (see below). The 451 
final volume will depend on the amount of plasmid subjected to precipitation, but the 452 
ideal concentration is 2-4 µg/µl. 453 
2. Pellet freshly purified sporozoites in a 50 ml universal tube using a swing bucket centrifuge (500 x 454 
g for 10 min), discard eluting buffer, and re-suspend parasites in the appropriate volume of P3 455 
buffer (20 µl per 1x106 sporozoites). 456 
In most cases, the use of fresh oocyst stocks and an adequate cracking, hatching and column 457 
purification will yield the best transfection efficiencies. In fact, we have previously shown an inverse 458 
correlation between parasite age and transfection efficiency (Clark et al., 2008). 459 
3. Add 1x106 sporozoites, 12 µg of the transfection construct(s) and 6 units of the restriction enzyme 460 
P3 buffer per well (final volume should not exceed 25 µl). If more than one plasmid is to be 461 
transfected, consider Avogadro’s constant to transfect equal copies of both plasmids (1 bp = 462 
660x106 µg/mole; 1 mole = 6.023x1023 copies). 463 
4. Dispense the appropriate volume into each well of the Nucleocuvette™ Strips, select the preset EO-464 
114 program from the Amaxa™ 4D-Nucleofector™ and start the nucleofection as indicated by the 465 
manufacturer.  466 
Nucleofection conditions and buffer composition are part of Lonza’s intellectual property, and 467 
therefore these cannot be modified. Other factors affecting transfection success are discussed in detail 468 
in the Methods for the optimisation of DNA integration section.  469 
Inclusion of mock transfected parasites (electroshocked with no DNA), and parasites transfected with 470 
previously tested plasmids can be useful to validate the nucleofection and determine the source of the 471 
issue, if any.  472 
Once transfected, sporozoites are considered as genetically modified organisms (GMO), and therefore, 473 
relevant legislations need to be reviewed and followed.   474 
5. Once shocked, add 80 µl of RPMI-1640 medium per well, and let the parasites stand for 15 min.  475 
6. Estimate survival rate by Trypan Blue exclusion using the cell counting chamber. Non-viable 476 
parasites whose membrane permeability is altered will take up the dye, turning blue. In our 477 
experience, survival rates ranging from 10 to 20% are considered adequate.  478 
7. Use the transfected parasites instantly for further in vivo or in vitro experiments. Alternatively, 479 
sporozoites can be transferred to 96-well plates in RPMI-1640 medium (~100 µl/well), left for 24-480 
48 h in an incubator (41 ºC, 5% CO2) to assess transfection efficiency under a fluorescence 481 
microscope.  482 
 483 
15 
 
BASIC PROTOCOL 3: In vitro propagation of E. tenella 484 
 485 
Eimeria tenella cannot complete its lifecycle in vitro efficiently, where its growth is confined to the early 486 
asexual stages of the parasite. Infection of cultured cells with purified sporozoites results in the 487 
development of first generation merozoites, but further progression to the second and third generation 488 
of merozoites and the subsequent gametogony is rarely observed in most systems. Moreover, it has 489 
been described that some strains (e.g. Wisconsin) are better adapted to cell culture and their replication 490 
is higher under this system (Doran, 1974). Earlier studies have shown that many different epithelial cell 491 
lines support development of E. tenella, but Madin-Darby bovine kidney (MDBK) cells appear to be best 492 
suited (Tierney & Mulcahy, 2003). The present protocol describes the cultivation of E. tenella asexual 493 
stages in MDBK cells in order to assess transfection success by analysis of reporter gene expression. 494 
 495 
Materials 496 
- MDBK (NBL-1) cells (Catalogue No: CCL-22, ATCC). 497 
- Freshly hatched sporozoites (see BASIC PROTOCOL 1: Cracking, hatching and purification of Eimeria 498 
tenella parasites section). 499 
- Advanced Dulbecco's Modified Eagle Medium (DMEM) (Catalogue No: 12491023, Gibco) 500 
supplemented with penicillin and streptomycin (100 U/ml each) (Catalogue No:  15140122, Gibco). 501 
- 0.025% Trypsin/0.01% EDTA solution (Catalogue No: R001100, Gibco). 502 
- Foetal bovine serum (FBS), heat inactivated. 503 
- Laminar flow hood. 504 
- CO2 incubator.  505 
- Cell culture 24-well plates (Catalogue No: 140685, Nunc) and T75 flasks (Catalogue No: 156499, 506 
Nunc). 507 
- Micropipettes, sterile tips, pipette controller and serological pipettes.  508 
 509 
Procedure 510 
1. MDBK cells can be passaged twice a week, using a subcultivation ratio of 1:2 to 1:4, and a 0.025% 511 
Trypsin/0.01% EDTA solution to detach adherent cells from the vessel. 512 
2. Dispense cells into 24 well culture plates (0.3x106 cells per well in 500 μl of advanced DMEM-2% 513 
FBS) and incubate at 41 ºC, 5% CO2 for at least 2 hours before infection.  514 
Recently settled and near confluent monolayers improve invasion rates and are critical for the 515 
experiment success. It is important to ensure that the cells are in an optimal condition before the 516 
experiment by tracking the cultures a few days in advance. 517 
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3. Prepare transfected sporozoites in a suspension of 0.3x106 parasites per ml in advanced DMEM-2% 518 
FBS. Do not keep sporozoites on ice, as this will reduce the degree of invasion achieved. 519 
A multiplicity of infection (MOI) 1:1 is recommended to follow the parasite lifecycle, but this can be 520 
modified based on the experimental requirements. Bear in mind that the use of a MOI of 4:1 may 521 
result in the destruction of the cell monolayer in less than 24 h.  522 
4. Carefully remove medium from cells and add 1 ml of sporozoite suspension per well. 523 
5. Allow sporozoites to infect the monolayer at 41 ºC, 5% CO2 for 2-4 h, by which time maximum 524 
invasion will have occurred. Carefully remove medium and replace with fresh advanced DMEM-2% 525 
FBS. 526 
If parasites are left invading for longer than 4 hours these could overload the monolayer causing its 527 
destruction within 24 hours. 528 
6. Incubate plates at 41 ºC for 24 for the observation of invaded sporozoites, or for 48 hours for the 529 
observation of schizogony and merozoite formation/release.  530 
7. The presence of fluorescent reporters in transgenic parasites can be followed and quantified by 531 
fluorescence microscopy (Figure 6). 532 
Analysis of fluorescence can be directly done in fresh or fixed monolayers on 24-well plates using an 533 
inverted microscope (up to 40x). If higher magnification is needed (up to 100x), cells can be seeded 534 
onto rounded coverslips placed in 24-well plates, fixed, and placed on microscope slides with mounting 535 
medium. 536 
 537 
BASIC PROTOCOL 4: In vivo propagation of transgenic E. tenella 538 
 539 
In vivo infection with transfected sporozoites results in the propagation of mainly wild-type parasites 540 
that did not integrate the coding sequence (construct) of interest, but also a small percentage of 541 
sporozoites that integrated the DNA construct and will generate transgenic oocysts during in vivo 542 
propagation (Figure 1). If selection markers such as drug resistance genes and/or fluorescent reporters 543 
are used, transgenic oocysts can be easily enriched by dietary drug supplementation and/or flow 544 
cytometry (see Use of markers for selection of transgenic Eimeria), and subsequently propagated in vivo 545 
(see Stability of the transgenes). This protocol describes the amplification of transgenic E. tenella 546 
populations in chickens, involving cloacal dosing, caecal harvest and sporulation of progeny oocysts, 547 
selection of transgenic parasites, and stabilization of transgenic populations.  548 
 549 
Materials 550 
- Transfected sporozoites. 551 
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- Coccidia-free chickens, 3-4 weeks old. All experiments must be approved by the appropriate local 552 
or national ethical review boards. 553 
- Floor wire cages, ideally previously fumigated with ammonia. 554 
- Water bath. 555 
- Swing bucket centrifuge. 556 
- Orbital shaker. 557 
- Flow cytometer.  558 
- 1 ml syringes. 559 
- Fine tipped Pasteur pipettes. 560 
- Silicon tubing (~4 cm length, 2 mm diameter). 561 
- 40 μm cell strainers (Catalogue No: 431750, Corning). 562 
- Dissecting tools. 563 
- Micropipettes, sterile tips, pipette controller and serological pipettes.  564 
- Cell counting chambers (modified Fuchs Rosenthal, catalogue No: AC6000, Hawksley). 565 
- Sterile baffled Erlenmeyer flask (borosilicate glass, narrow neck, 1,000 ml, catalogue No: 1134/12, 566 
Pyrex). 567 
- Centrifuge bottles.  568 
- Parafilm.  569 
- Distilled water. 570 
- Pyrimethamine (Catalogue No: 46706, Sigma-Aldrich). 571 
- Sterile phosphate buffered saline (PBS), pH 8 (see Reagents and solutions). 572 
- Trypsin from porcine pancreas (Catalogue No: T4799, Sigma-Aldrich). 573 
- Sterile 2% potassium dichromate (supplied at 6% dilute down to 2% for use). 574 
- Sterile saturated salt solution (SSS) (see Reagents and solutions). 575 
- 1.2% sodium hypochlorite solution (from 12% stock solution, catalogue No: 301696S, VWR 576 
Chemicals). 577 
 578 
Procedure 579 
1. Withdraw feed from cages 3 h before cloacal dosing to prevent transgenic sporozoites being 580 
expelled with droppings.  581 
2. Gently dose birds with transfected sporozoites via the cloaca (up to 150,000 live parasites per bird, 582 
diluted in up to 500 μl of RPMI-1640). A dosing catheter can be crafted with a 1 ml syringe coupled 583 
to silicone tubing, using the cut off end of a fine tipped Pasteur pipette as an adaptor between the 584 
syringe and the silicone tubing. Once dosed, chicken feed can be replaced in cages. 585 
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Freshly transfected sporozoites are administered to chickens via the cloaca. This prevents degradation 586 
of the sporozoites in the proventriculus, as they are not protected by the oocyst wall. When a parasite 587 
suspension is dripped onto the cloacal lips, it shows a typical sucking movement that uptakes the fluid, 588 
resulting in an effective lower intestinal infection.  589 
3. If the DHFR-TSm2m3 gene has been included in the transfected construct, supplement the diet with 590 
150 ppm of pyrimethamine 24 h after dosing, and keep feeding all chickens with this for 6 days. To 591 
ensure homogeneous distribution of the drug, feed can be ground and mixed using a mixing 592 
paddle. 593 
4. One week after infection, cull chickens and remove the caeca using dissecting tools. 594 
5. Carefully cut each caecum open longitudinally. Holding the tip of each caecum with one glass 595 
microscope slide, use a second slide to carefully scrape away the caecal contents, the mucosal and 596 
the deeper muscle layers (Figure 7A). Place the scrapings in a 50 ml tube containing PBS or distilled 597 
water (1:1 proportion). 598 
6. Add trypsin to 1.5% (w/v) of the total volume to break down any connective tissue. Incubate in a 599 
water bath at 41 ºC for ~90 min, swirling the tube frequently. 600 
An adequate scraping technique and trypsin digestion will improve oocyst yields, as the parasites will 601 
not be trapped within caecal tissues and will be easier to recover. 602 
7. Centrifuge homogenate (750 x g for 10 minutes), and discard supernatant. Then, wash the resulting 603 
pellet twice using distilled water and re-pellet by centrifugation. Check microscopically all 604 
supernatants to confirm that oocysts are not being lost during washes. 605 
8. To start oocyst sporulation, enumerate the number of oocysts using a cell counting chamber and 606 
dilute them with 2% (w/v) potassium dichromate to a final concentration of 0.1-0.25x106 oocysts 607 
per ml using a baffled flask of at least twice the culture volume. 608 
Since sporulation depends on aeration, the use of a baffled flask of at least twice the culture volume 609 
is highly desirable. We do not recommend the use of air pumps coupled to serological pipettes, as this 610 
system increases the chances to cross-contaminate adjacent cultures.  611 
9. Seal the flask with parafilm, pierce it using micropipette tips to ensure aeration, clamp the flask on 612 
an orbital shaker, and shake it at 50-100 rpm for 72-96 h at 26-28 ºC.   613 
Although oocyst walls are relatively resistant, if shaking is too vigorous during sporulation it may 614 
result in oocyst breakage, and therefore, loss of viable parasites. 615 
10. During sporulation check oocysts microscopically to estimate sporulation rate using a counting 616 
chamber. Rates over 85% are expected. 617 
11. Once sporulation has finished, pour the oocyst suspension into centrifuge bottles or 50 ml tubes 618 
and centrifuge (750 x g for 10 minutes). Carefully discard the supernatant using a serological pipette 619 
and check microscopically that all oocysts have been pelleted. 620 
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We always recommend the use of swing rotor centrifuges to pellet oocysts and serological pipettes or 621 
vacuum pumps to discard supernatants. When experiencing difficulties to pellet oocysts, it is advisable 622 
to dilute the sample with distilled water to reduce residual flotation.  623 
Consider current GMO regulations for waste disposal. Aim to autoclave all vessels and solutions that 624 
have been in contact with transgenic parasites before disposal. 625 
12. Wash the oocyst pellet three times with distilled water by centrifugation (750 x g for 10 minutes), 626 
checking microscopically that all oocysts have been pelleted from all supernatants. Aim to 627 
constantly reduce the volume. 628 
13. Re-suspend the pellet in 5-10 ml of 1.2% sodium hypochlorite solution in a 50 ml tube. Treat for 5-629 
10 minutes and swirl intermittently. 630 
14. Top up the vessel with distilled water, mix and centrifuge to pellet the oocysts (750 x g for 10 631 
minutes). Carefully discard the supernatant using a serological pipette and check microscopically 632 
that all oocysts have been pelleted. 633 
15. Re-suspend the pellet in SSS thoroughly using a Pasteur pipette and leaving no lumps.  634 
16. Fill the 50 ml tube to 40 ml with SSS and overlay with distilled water by gently running the water 635 
down the side of the tube with a Pasteur pipette to 45 ml. Then centrifuge at 750 g for 10 minutes. 636 
17. Collect the parasites at the interface between the salt and water phases with a Pasteur pipette 637 
(Figure 7B). Dispense into a suitable tube and add at least double the volume of water. After the 638 
oocyst layer has been removed, check the pellet at the bottom of the tube microscopically for any 639 
remaining oocysts. If a significant number are observed, then repeat the salt flotation as in step 14. 640 
18. Centrifuge recovered oocysts at 750 x g for 10 minutes, discard supernatant and re-suspend in 641 
water. Repeat this two more times, checking microscopically that all oocysts have been pelleted 642 
from all supernatants. 643 
19. After the final wash, re-suspend the oocysts in a suitable volume of distilled water and enumerate 644 
using a cell counting chamber (see BASIC PROTOCOL 1: Cracking, hatching and purification of 645 
Eimeria tenella parasites).  646 
20. Once purified, oocysts can be stored at 4 ºC in a universal tube (preferably made of glass) and used 647 
for up to 6 months.  648 
We have observed that oocysts viability declines progressively over the time as shown by the decrease 649 
in subsequent oocyst output when old parasite stocks are used to dose new batches of birds. In these 650 
cases, infection doses need to be increased 2-fold or more to achieve similar oocyst yields. However, 651 
this must be done with caution, as it could result in the induction of severe caecal lesions and the 652 
death of the animal. When trying to refresh valuable oocysts older than 6 months, one should aim to 653 
recover low numbers of fresher parasites than can be subsequently passaged in new birds using the 654 
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recommended dose (4,000 oocysts/bird) to obtain substantial amounts of parasites without inducing 655 
severe pathology.  656 
21. If a fluorescent reporter has been transfected, recovered oocysts: 657 
a. Can be analysed by fluorescent microscopy. 658 
b. Can be submitted to cracking, hatching and purification as described above in order to: 659 
i. analyse the localisation of the fluorescent tag within the sporocyst and/or sporozoite, 660 
or 661 
ii. infect MDBK cells and let them develop to first generation merozoites to track 662 
transgene behaviour on different parasite stages. 663 
c. Can be sorted by flow cytometry. FACS settings will depend on the equipment available, the 664 
reporter transfected, the experimental needs, etc. In general, pre-filtering the parasites through 665 
40 μm cell strainers is highly recommended. Sorting oocysts at relatively high pressure (40 psi) 666 
using 70 to 100 µm nozzles does not seem to impact their viability, yielding recovery rates up 667 
to 96%. Gate out strategies to discard cell debris (by cell complexity analysis) and to select 668 
fluorescent parasites at specific thresholds are also recommended (Figure 8). 669 
22. In order to increase the ratio of transgenic/wild type parasites, and stabilise transgenic populations, 670 
sorted parasites should be used to infect successive new batches of coccidia-free birds employing 671 
doses up to 4,000 oocysts per bird by oral gavage, and progeny oocysts can be recovered and 672 
selected again as detailed above. 673 
 674 
REAGENTS AND SOLUTIONS 675 
 676 
Sterile saturated salt solution (SSS, 6.4 M NaCl)  677 
1. Mix 375 g of NaCl with 1 litre of boiling ultrapure water and leave overnight at room 678 
temperature. 679 
2. The day after check that the specific gravity is within the expected range (1.18 - 1.20) using a 680 
hydrometer. 681 
3. Autoclave the solution (121 ºC, 15 min). The presence of undissolved salt is normal, this helps 682 
to maintain saturation of the solution.  683 
Sterile phosphate buffered saline (PBS)  684 
1. Prepare a solution containing 95 mM Na2HPO4, 6.5 mM NaH2PO4 and 72 mM NaCl in ultrapure 685 
water. 686 
2. Adjust pH to 8 and autoclave (121 ºC, 15 min). 687 
3. This buffer can also be prepared as a 4X stock solution and autoclaved (121 ºC, 15 min). 688 
 689 
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Sterile diethylaminoethyl cellulose 690 
1. Mix DE-52 (Whatman pre-swollen microgranular anion exchange; Catalogue No: 4057-050) with 691 
sterile 1X PBS (~75 ml per gram) and allow to settle for 30-60 min. 692 
2. Discard supernatant to remove small particles, add more sterile PBS, mix and allow to settle for 693 
30-60 min. 694 
3. Discard supernatant to remove small particles, add more sterile PBS (~25 ml per gram), mix and 695 
adjust to pH 8.0 with 5% (w/v) H3PO4.  696 
4. Allow DE-52 to settle overnight at 4 ºC. 697 
5. Remove supernatant, leaving a small amount of PBS on top of the DE-52, and autoclave solution 698 
(121 ºC, 15 min). 699 
Hatching Solution 700 
1. Mix 9.8 g Hanks’ Balanced Salts (Catalogue No: H6136, Sigma-Aldrich), 10 g sodium 701 
taurocholate hydrate (Catalogue No: 86339, Sigma-Aldrich), and 2.5 g trypsin from porcine 702 
pancreas (Catalogue No: T4799, Sigma-Aldrich) in 950 mL of ultrapure water. 703 
2. Adjust to pH 8.0, make up to 1000 ml, aliquot in 50 ml universal tubes, and store at -20 ºC. If 704 
required, this solution can be sterile filtered using 0.2 µm membranes prior to freezing. 705 
Eluting buffer (PBS-1% glucose) 706 
1. Dissolve 1 g of glucose per 100 mL of sterile PBS pH 8. This buffer can be prepared as a 10X 707 
stock solution (10 g of glucose per 100 mL of sterile PBS pH 8), filtered using 0.2 µm membranes, 708 
and stored at 4 ºC for several months. 709 
 710 
 711 
COMMENTARY: PREVIOUS CONSIDERATIONS 712 
 713 
Selection of Eimeria species 714 
 715 
The first successful transient complementation of Eimeria spp. was described in E. tenella sporozoites 716 
using the beta-galactosidase reporter (Kelleher & Tomley, 1998). Almost ten years later, two studies 717 
described the stable complementation of the same species with specific fluorescent reporters (Clark et 718 
al., 2008; Yan et al., 2009). In all examples, the choice of E. tenella was not arbitrary, since it is the species 719 
most capable of invading, replicating and developing in vitro in a range of primary cells and established 720 
cell lines (most notably the E. tenella Wisconsin strain) (Doran, 1974). Nevertheless, E. tenella in vitro 721 
development is largely limited to the early asexual stages, and fails to support efficient sexual replication 722 
and the subsequent production of oocysts, meaning that parasite propagation is only feasible through 723 
controlled passage using live animals (Bussière et al., 2018). In addition, of the Eimeria species which 724 
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can infect the chicken, E. tenella preferentially replicates in the caeca, simplifying its harvest from caecal 725 
scrapes instead of faecal samples (Eckert J., 1995). This approach also reduces the amount of clinical 726 
waste generated, and simplifies adherence to relevant regulations regarding genetically modified 727 
organisms. Transgenic E. tenella parasites can still induce severe haemorrhagic lesions if uncontrolled 728 
doses are administered to chickens. Thus, the use of highly prolific and less pathogenic species such as 729 
Eimeria acervulina for genetic complementation would be highly beneficial (Zou et al., 2009). To date, a 730 
number of studies have shown evidence of successful transfection not only in most of the Eimeria 731 
species affecting poultry (E. acervulina, E. maxima, E. mitis, E. praecox in addition to E. tenella), but also 732 
in other Eimeria species from rats and rabbits (E. nieschulzi, E. intestinalis) (Blake et al., 2011; Kurth & 733 
Entzeroth, 2009; Qin et al., 2014; Shi et al., 2016; Zou et al., 2009), which suggests that most Eimeria 734 
species would be suitable for transfection following the protocols hereby described.  735 
 736 
Use of targeting signals to modify transprotein delivery 737 
 738 
The use of Eimeria species parasites as live replicating vectors has been proposed as a method to 739 
express pathogen-derived antigens, protect them from gastric digestion, and deliver them directly to 740 
the gastrointestinal system. However, a number of studies carried out with transgenic Leishmania major, 741 
Trypanosoma cruzi, T. gondii, and E. tenella have shown that the nature of the immune response elicited 742 
by such delivery differs depending on the subcellular localisation of the expressed foreign antigen 743 
(Bertholet et al., 2005; Garg, Nunes, & Tarleton, 1997; Gregg et al., 2011; Huang et al., 2011; Kwok et al., 744 
2003; Pepper, Dzierszinski, Crawford, Hunter, & Roos, 2004). Initial work carried out with stable 745 
populations of transgenic Eimeria described that the transgenes were mostly expressed, and therefore 746 
retained, in the sporozoite cytosol (Clark et al., 2008). Nevertheless, recent studies have successfully 747 
exploited the inclusion of specific delivery signals within transfection constructs to modify transgene 748 
trafficking, hypothetically improving antigen exposure to the host immune system. Delivery sequences 749 
which have been tested in Eimeria spp. include: (i) the signal peptide from the T. gondii dense granule 750 
protein 8 (GRA8), the repetitive interspersed family protein in Plasmodium falciparum, and the signal 751 
peptide from the E. tenella SAG1 protein, targeting the transprotein to the parasitophorous vacuole 752 
membrane (Liu et al., 2008; Shi, Yan, Ren, Liu, & Suo, 2009); (ii) the nuclear localization sequence (NLS) 753 
from the E. tenella histone H4 protein, which tags a protein for import into the cell nucleus (Liu et al., 754 
2008); (iii) the signal peptide from the E. tenella MIC1 protein, which targets the transprotein into the 755 
micronemes (Huang et al., 2011); (iv) the signal peptide from the E. tenella MIC2 protein, which induces 756 
the secretion of the transfected protein into the sporocyst cavity after oocyst sporulation (Marugan-757 
Hernandez et al., 2017); and (v) the glycophosphatidylinositol (GPI) anchor sequence from the E. tenella 758 
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SAG1 protein, that induces the anchorage of the protein onto the sporozoite surface (Marugan-759 
Hernandez et al., 2017). 760 
 761 
Present limitations for transfection in Eimeria parasites 762 
 763 
Current techniques available for Eimeria spp. transfection still rely on random, non-homologous 764 
insertion of plasmid DNA, which entails two main limitations. Firstly, DNA integration through REMI (see 765 
Restriction enzyme mediated integration) results in extremely high rates of insertion, reducing the 766 
likelihood to obtain stable populations. Secondly, non-directed transfections are likely to disrupt 767 
essential regions of the genome, increasing the mortality rate of the transfectants. In addition, the 768 
inefficiency of in vitro cultivation to propagate Eimeria spp. obstructs generation of genetically 769 
homogeneous (clonal) lines, and consequently yields highly variable results (Qin et al., 2014). 770 
Furthermore, while the sexual stages of the Eimeria lifecycle take place in vivo, genetic segregation and 771 
recombination occur during oocyst sporulation ex vivo, remote from selectable markers such as drug 772 
selection or enrichment for fluorescent reporter proteins. This results in transgene loss due to cross-773 
fertilisation between transgenic and non-transgenic parents (Clark et al., 2008). The occurrence of this 774 
phenomenon is clear when parasites are transfected for the first time with fluorescent reporters, used 775 
to infect birds, and analysed under fluorescence microscopy after harvest, when it is possible to observe 776 
progeny oocysts carrying one, two, three, and/or four fluorescent sporocysts (Kurth & Entzeroth, 2009). 777 
However, stabilization of parasite populations by successive in vivo passage seemingly contributes to 778 
reduce this effect as discussed in Stability of the transgenes section. The generation of KU80 knockout 779 
mutant strains (Fox, Ristuccia, Gigley, & Bzik, 2009; Huynh & Carruthers, 2009) and development of the 780 
CRISPR/Cas9 system in Toxoplasma gondii (Shen, Brown, Lee, & Sibley, 2014; Sidik, Hackett, Tran, 781 
Westwood, & Lourido, 2014) have significantly improved homologous integration efficiency and 782 
disruption of targeted genes in this parasite system, but unfortunately these technologies are not yet 783 
available for Eimeria. Nevertheless, and despite all these inconveniences, the protocols described here 784 
have proven to be of value for generating stable transgenic populations of Eimeria spp. (Clark et al., 785 
2008; Yan et al., 2009).  786 
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TABLES  929 
 930 
Table 1. Putative promoter regions of E. tenella selected to test their ability to induce specific or higher 931 
levels of expression of foreign genes transfected in E. tenella sporozoites. Accession numbers 932 
(http://www.toxodb.org), relative transcript abundances, stage-specific regulations, ortholog/paralog 933 
products (compared to Toxoplasma gondii and Neospora caninum), and levels of mCitrine expression 934 
after transfection of sporozoites are displayed. 935 
 936 
Promoter 
region 
Accession 
number 
(ToxoDB) 
Expression 
level (mRNA) 
Expression 
regulation 
Product 
Fluorescence 
levels 
(mCitrine) 
Et1 ETH_00000210 High Constitutive 
Heat shock protein 70, 
related / RNA recognition 
motif domain-containing 
protein, putative 
+ 
Et2 ETH_00004225 High 
Sporulated oocyst 
& sporozoite 
No homologous + 
Et3 ETH_00004795 Medium Constitutive No homologous + 
Et4 ETH_00004955 High 
Sporozoite 
& merozoite 
No homologous + 
Et5 ETH_00009335 Medium Constitutive 
Zinc finger (C3HC4 RING 
finger) protein, putative 
- 
Et6 ETH_00009460 High Constitutive 
Putative pyruvate 
dehydrogenase (lipoamide) 
kinase 
+ 
Et7 ETH_00010410 Medium Constitutive Hypothetical protein - 
Et8 ETH_00025365 High Constitutive 
Putative translation initiation 
factor SUI1 
+++ 
Et9 ETH_00031740 High Constitutive No homologous ++ 
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Table 2. The set of programmes assessed for optimization of transfection in E. tenella using the Amaxa™ 948 
4D-Nucleofector™ System. Transfection was carried out using 1x106 freshly purified sporozoites, 5 μg 949 
of plasmid DNA carrying the mCitrine reporter, and 0.5 U of the Scal restriction enzyme per well, and 950 
assessed by visual confirmation of sporozoite fluorescence. ❌: shock failure. ✓: shock successful. NF: no 951 
fluorescent sporozoites observed. F: fluorescent sporozoites observed. 952 
 953 
AMAXA™ 4D 
Program 
Cytomix buffer P1 buffer P3 buffer P4 buffer 
EO-115 ❌, NF ✓, NF ✓, NF ✓, NF 
FI-115 ❌, NF ✓, NF ✓, NF ✓, NF 
FP-167 ❌, NF ✓, NF ✓, NF ✓, NF 
FP-158 ❌, NF Not tested ✓, NF Not tested 
FB-158 ❌, NF Not tested ❌, NF Not tested 
EZ-158 ❌, NF ✓, NF ✓, NF ✓, NF 
FI-158 ❌, NF Not tested SF, NF Not tested 
ES-100 Not tested ✓, NF ✓, NF ✓, NF 
FF-158 Not tested ✓, NF ✓, NF ✓, NF 
ER-115 Not tested ✓, NF ✓, NF ✓, NF 
EX-115 Not tested ✓, NF ✓, NF ✓, NF 
EO-114 Not tested ✓, NF ✓, F ✓, NF 
FB-115 Not tested ❌, NF ✓, NF ✓, NF 
FA-115 Not tested ✓, NF ✓, NF ✓, NF 
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FIGURES AND FIGURE LEGENDS 965 
 966 
Figure 1. Strategy for genetic complementation of Eimeria tenella parasites. Sporozoites are purified 967 
from oocysts, transfected with the construct of interest (e. g. including mCitrine, a fluorescent reporter) 968 
using nucleofection systems and immediately used to infect coccidia-free chickens via the cloaca. A 969 
week after infection, progeny oocysts can be harvested from the caeca of infected chickens, sporulated, 970 
and subjected to fluorescence-activated cell sorting (FACS) to select those parasites expressing the 971 
fluorescent reporter. Enriched populations of fluorescent parasites can then be used to infect new 972 
batches of coccidia-free chickens by oral gavage, thereby stabilizing the population. 973 
 974 
 975 
 976 
 977 
 978 
 979 
 980 
  981 
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Figure 2. Effect of pEtenREPORTER plasmid concentration on percentage of fluorescent oocysts 982 
recovered after in vivo passage using coccidia-free chickens. Groups marked with * were significantly 983 
different (P<0.05; Fisher's exact test). 984 
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 999 
 1000 
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Figure 3. Effect of PsiI and ScaI restriction enzymes for REMI using either 5.0 or 3.5 µg of digested 1003 
plasmid DNA. A: Percentage survival of sporozoites immediately after transfection by Trypan blue 1004 
exclusion. B: Relative fluorescence intensity of sporozoites 24 h after transfection. C: Percentage of 1005 
fluorescent sporozoites 24 h after transfection. *: P<0.05; **: P<0.01; ***: P<0.001 (one way ANOVA 1006 
test). 1007 
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Figure 4. Effect of repeated in vivo passage on transgenic E. tenella populations. Six different batches 1030 
of sporozoites were transfected with 12 µg of the same ScaI-digested construct (pCIT-CjaA plasmid 1031 
containing the mCitrine sequence and an additional cassette coding for the Campylobacter jejuni 1032 
antigen A, from Clark et al., 2012) and the ScaI endonuclease using the EO-114 program (AMAXA™ 4D-1033 
Nucleofector™ System). Transgenic parasites were independently propagated up to four times in 1034 
coccidia-free birds using FACS-enriched populations between passages. A: Average transgene copy 1035 
number from the six different populations as determined by quantitative PCR using mCitrine as target 1036 
and the Et5S gene as internal control (Log10 scale). B: Percentage of fluorescent parasites out of the 1037 
total harvested parasites per passage as visualised under fluorescence microscopy. 1038 
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Figure 5. A: Photomicrographs of oocysts cracked using glass beads. The yellow box delimits an area 1051 
full of oocyst shells. The pink arrow points to a non-cracked oocyst, white arrows indicate released and 1052 
unaltered sporocysts, and the yellow arrows show damaged sporocysts due to excessive cracking. Bars 1053 
represent 20 μm. B: Representation of a column for purification of sporozoites using teased out nylon 1054 
wool and DE-52 cellulose, and the appearance of purified sporozoites under the microscope (bar 1055 
represents 20 μm). 1056 
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Figure 6. In vitro culture of transgenic Eimeria tenella Wisconsin parasites expressing the mCitrine 1063 
reporter in MDBK cells. A: intracellular sporozoites after 24 h of infection. Only those successfully 1064 
transfected show green fluorescence. B: late development schizonts showing green fluorescence 48 h 1065 
after infection. In both cases sporozoites that did not integrate the mCitrine reporter can still be 1066 
visualized (white arrows). Bars represent 20 μm. 1067 
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Figure 7. A: Schematic representation of caeca scrapping technique. B: Flotation of E. tenella oocysts 1090 
after sodium hypochlorite treatment using saturated salt solution (SSS). Oocysts are present at the 1091 
interface between the SSS and water phases. 1092 
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Figure 8. Flow cytometry analysis of transgenic E. tenella parasites expressing the mCitrine reporter 1116 
after first in vivo passage. Top: exclusion of cell debris by SSC-A/FSC-A gating. Bottom: selection of 1117 
FITC-positive parasites for sorting. Red arrow and box: transgenic parasites expressing mCitrine (note 1118 
that they represent a minority among the whole population, ~1.4%). SSC-A: side scattered area; FSC-A: 1119 
forward scattered area; FITC-A: Fluorescein isothiocyanate area. 1120 
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